Cures Start Here. Fred Hutchinson Cancer Research Center, home to three Nobel laureates, is an independent, nonprofit research institute based in Seattle. Its interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Research from its Basic Sciences Division is the foundation for ultimately understanding the causes of and developing the treatments for human disease. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employeeswho bringdifferent and innovativeways of seeing the world and solving problems.Fred Hutch is in pursuit of becoming an antiracist organization.Weare committed to ensuring that all candidates hired share our commitment to diversity,antiracism, and inclusion.
A postdoctoral fellow position in Molecular Neuroscience/Neurodegeneration is available in the Fred Hutch lab of Dr. Linda Buck. Dr. Buck received a Nobel Prize in Physiology or Medicine in 2004 for Odorant receptors and the organization of the olfactory system. Current projects in the Buck lab focus on molecular mechanisms that underlie stress, appetite, and neurodegeneration and how they are influenced by the olfactory system. The lab has developed and uses cutting edge technologies to unravel neural mechanisms and neural circuits underlying specific functions/dysfunctions. These include novel genomics methods to define neural circuits, genetic and chemical control of neuronal activation, imaging of gene expression and neuronal activation, gene editing, and single cell genomics.
The fellow will be responsible for developing and executing a project related to current and future interests of the lab, as determined by discussions with Dr. Buck. The successful candidate will be an individual who is enthusiastic about science and is capable of independent research.
PhD in molecular/cell biology, molecular neuroscience, computational biology, or related field
Excellent knowledge of fundamental molecular and cell biology
Experience using molecular techniques for cloning and for analysis of nucleic acids and proteins
Experience using immunohistochemistry and/or in situ hybridization for analyses of gene expression
Experience with RNA sequencing and bioinformatics
Experience in mouse breeding and genotyping
Knowledge of neuroscience
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our HR Operations at HRops@fredhutch.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.